4//SEC Filing
Kropotova Alexandra 4
Accession 0001209191-22-034919
CIK 0001833214other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 8:00 PM ET
Size
5.2 KB
Accession
0001209191-22-034919
Insider Transaction Report
Form 4
Kropotova Alexandra
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2022-06-06+300,000→ 300,000 total
Footnotes (2)
- [F1]Restricted Stock Unit ("RSU") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on June 6, 2023, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001825323
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 8:00 PM ET
- Size
- 5.2 KB